Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

GYROSCOPE THERAPEUTICS HOLDINGS PLC

(VISN)
 SummaryQuotesNewsCompanyFinancials 
Estimated financial data (e) (USD)
Sales 2019
Net income 2019
Net Debt 2019
P/E ratio 2019
Yield 2019
Sales 2020 2,97 M - -
Net income 2020 -33,5 M - -
Net cash position 2020 12,6 M - -
P/E ratio 2020 -
Yield 2020 -
Capitalization 614 M 614 M -
EV / Sales 2019
EV / Sales 2020 -
Nbr of Employees 167
Free-Float 49,5%
More Financials
Company
Gyroscope Therapeutics Holdings plc, formerly Gyroscope Therapeutics Holdings Limited, is a clinical-stage gene therapy company. The Company develop gene therapy beyond rare diseases. It offers therapies to treat diseases of the eye that cause vision loss and blindness. The Company’s investigational gene therapy, GT005, is in Phase II clinical trials for the treatment of geographic atrophy (GA) secondary to... 
More about the company
All news about GYROSCOPE THERAPEUTICS HOLDINGS PLC
11/08Syncona Says Sanofi to Invest up to $60 Million in Gyroscope Therapeutics
DJ
11/08Gyroscope Therapeutics Holdings plc announced that it expects to receive ?44.5 million ..
CI
09/30Gyroscope Therapeutics Holdings plc Announces Presentation of Positive Interim Phase I/..
CI
06/22Gyroscope Therapeutics Announces Research Collaboration Agreement with Children’s Medic..
CI
05/07Gyroscope Therapeutics Holdings plc has withdrawn its IPO in the amount of $148.5 milli..
CI
04/16Gyroscope Therapeutics Holdings plc has filed an IPO in the amount of $100 million.
CI
01/11Gyroscope Therapeutics Holdings Limited Auditor Raises 'Going Concern' Doubt
CI
2019Gyroscope Therapeutics Limited acquired Orbit Biomedical Inc. from Syncona Portfolio Lt..
CI
More news
News in other languages on GYROSCOPE THERAPEUTICS HOLDINGS PLC

- No features available -

More news
Chart GYROSCOPE THERAPEUTICS HOLDINGS PLC
Duration : Period :
Gyroscope Therapeutics Holdings plc Technical Analysis Chart | VISN | US40382N1037 | MarketScreener
Income Statement Evolution
Managers and Directors
Khurem Farooq Chief Executive Officer & Director
Jessica Stitt Chief Financial Officer
Christopher John Hollowood Chairman
Jane Hughes Chief Scientific Officer
Ian Pitfield Senior Vice President-Technical Operations
Sector and Competitors
1st jan.Capi. (M$)
GYROSCOPE THERAPEUTICS HOLDINGS PLC0.00%614
MODERNA, INC.237.35%142 893
LONZA GROUP AG30.63%59 859
IQVIA HOLDINGS INC.44.63%49 504
SEAGEN INC.-8.64%29 257
CELLTRION, INC.-42.34%23 827